SCHEMBL5486970

SCHEMBL5486970

CCC(C(N)=O)C(=O)Nc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
SMN1; SMN2 Q16637 3/20 0.50
TAAR1 Q96RJ0 1/20 0.50
MME P08473 1/20 0.50
ACE P12821 1/20 0.50
ALDH1A1 P00352 4/20 0.49
MAPT P10636 3/20 0.49
KLK7 P49862 1/20 0.49
MAPK1 P28482 1/20 0.49
LMNA P02545 3/20 0.49
GAA P10253 1/20 0.49
ATM Q13315 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
POLB P06746 1/20 0.49
CRHBP P24387 2/20 0.48
CRHR2 Q13324 2/20 0.48
HTT P42858 1/20 0.48
METAP2 P50579 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14853295 0.89 MEN1 (0.64) MEN1KMT2ASMN1; SMN2MMEACE
SCHEMBL5550287 0.87 MEN1 (0.67) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL11394858 0.84 ALDH1A1 (0.59) MEN1KMT2ASMN1; SMN2MMEACE
SCHEMBL8243069 0.83 ALDH1A1 (0.53) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL5902551 0.80 ALDH1A1 (0.61) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL9515306 0.79 ALDH1A1 (0.56) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL10791327 0.79 MEN1 (0.60) MEN1KMT2ASMN1; SMN2TAAR1MME
SCHEMBL5270163 0.79 MEN1 (0.60) MEN1KMT2ASMN1; SMN2TAAR1MME
SCHEMBL14209990 0.79 MEN1 (0.60) MEN1KMT2ASMN1; SMN2TAAR1MME
SCHEMBL4681925 0.78 MEN1 (0.86) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007525670-A 2007-09-06 JP claimed
EP-1718971-A2 SYSTEM AND METHOD FOR REAL-TIME DIAGNOSIS, TREATMENT, AND THERAPEUTIC DRUG MONITORING UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2006-11-08 EP claimed
WO-2005098429-A2 SYSTEM AND METHOD FOR REAL-TIME DIAGNOSIS, TREATMENT, AND THERAPEUTIC DRUG MONITORING UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2005-10-20 WO claimed
EP-0511003-B1 Superactive GRF analogs LILLY CO ELI (US) 1999-03-24 EP disclosed
EP-0511003-A1 Superactive GRF analogs ELI LILLY AND COMPANY (US) 1992-10-28 EP disclosed